Secondary Logo

Share this article on:

The correlation between affected renal function and affected renal residual volume

A retrospective outcome of laparoscopic nephron-sparing partial nephrectomy with segmental renal artery blocking-up for localized renal tumors

Chen, Fang-Min, MD, PhDa,*; Hu, Rui-Jie, MDb; Jiang, Xi-Nan, MDc; Zhong, Si-Wen, MDc; Tang, Shuai, MDa

Section Editor(s): Mancini., Vito

doi: 10.1097/MD.0000000000013927
Research Article: Observational Study

Laparoscopic nephron-sparing partial nephrectomy with segmental renal artery blocking (SRPN) has been widely used in the treatment of localized renal tumors. However, the impact of ischemia-reperfusion injury (IRI) during SRPN remains controversial. This study aims to evaluate the correlation between affected renal function and affected renal volume after SRPN for localized renal tumor treatment, explore the effect of IRI on renal function after SRPN.

A total of 39 patients who underwent SRPN for localized renal tumor from June 2009 to April 2012 were reviewed. These patients were followed-up for 5 years. The preoperative affected renal glomerular filtration rate (aGFRpre), postoperative affected renal glomerular filtration rate (aGFRpost), preoperative affected renal volume (aVolpre), and postoperative affected renal volume (aVolpost) were collected during the follow-up period. The correlation between aGFRpost/aGFRpre and aVolpost/aVolpre was compared.

A total of 33 patients were successfully followed up. After 3, 6, 12, 24, and 60 months, aGFRpost was 34.6 ± 4.6, 34.7 ± 4.8, 34.9 ± 4.4, 35.1 ± 4.4, and 35.2 ± 4.2 mL/min. The correlation coefficients between aGFRpost/aGFRpre and aVolpost/aVolpre were 0.659 (P = .000), 0.667 (P = .000), 0.663 (P = .000), 0.629 (P = .000), and 0.604 (P = .000), respectively. The limitation of this study was the small cohort size.

For the localized renal tumor, aGFRpost was associated with aVolpost, but was not associated with intraoperative factors, such as the time of clamping of the affected segmental renal artery. As a part of nephrons, the resected tumor tissue caused the lack of inherent nephrons, resulting in the loss of renal function. More nephrons should be maintained before resecting the tumor completely during SRPN.

Trial registration: ChiCTR-RRC-17011418.

aDepartment of Urology, The Third Central Hospital of Tianjin, Tianjin Key Laboratory of Artificial Cell; Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin

bThe First People's Hospital of Jiujiang City, Jiujiang, Jiangxi

cDepartment of Urology, Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

Correspondence: Fang-Min Chen, Department of Urology, The Third Central Hospital of Tianjin, Jintang Road, Tianjin 300170, China (e-mail:

Abbreviations: aGFRpost = postoperative affected GFR, aGFRpre = preoperative affected GFR, aVolpost = postoperative affected renal residual volume, aVolpre = preoperative affected renal volume, BMI = body mass index, CT = computed tomography, DFS = disease-free survival, eGFR = estimated glomerular filtration rate, GFR = glomerular filtration rate, IRI = ischemia-reperfusion injury, LPN = laparoscopic partial nephrectomy, OS = overall survival, PN = partial nephrectomy, WIT = warm ischemic time.

F-MC and R-JH contributed equally to this work.

Jinmen Medical Talents Project of Tianjin [Grant no. JMTP (2018) 0015]; International Science and Technology Cooperation Project of Guizhou Province [Grant no. QKHWGZ (2011)7015]; Science and Technology Fund Project of Guizhou Province [Grant no. QKHZ (2013)2029].

The authors declare that they have no competing interests.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Received July 5, 2018

Received in revised form December 3, 2018

Accepted December 5, 2018

Back to Top | Article Outline

1 Introduction

Partial nephrectomy (PN) has been demonstrated to be safe and feasible for localized renal tumor. Furthermore, PN has been recommended for the treatment of localized renal cell carcinoma by the European Association of Urology in 2014,[1,2] including open partial nephrectomy, laparoscopic partial nephrectomy (LPN), and robot-assisted partial nephrectomy. Renal hilar control, including main renal arterial clamping, segmental renal arterial clamping, and selective arterial clamping, which is guided by near-infrared fluorescence imaging, without arterial clamping and targeted vascular microdissection, is crucial to ensure a clear operative area during PN, and plays a prominent role in surgery. The methods for renal hilar control have been confirmed to be safe and feasible.[3–7] Given the challenges of main renal artery clamping, other methods have emerged as novel techniques to facilitate minimally invasive surgery by blocking the delicate blood-supply of the tumor and reducing ischemia-reperfusion injury (IRI) to the residual nephron during the operation. Due to the economic burden of patients in certain places in China, the da Vinci Si Surgical System could not be implemented. LPN is a minimally invasive procedure for small renal tumors,[7–10] and laparoscopic nephron-sparing partial nephrectomy with segmental renal artery blocking (SRPN) has been the routine treatment in the Affiliated Hospital of Guizhou Medical University and the Third Central Hospital of Tianjin.

PN surgery has been widely used as a standard of care for localized small renal tumors,[2,7,11] but factors that affect postoperative renal function have been highlighted in previous researches.[12–14] Warm ischemic time (WIT) has been considered the main factor influencing postoperative renal function after PN for a long period of time,[12,15–17] and some articles[16,18,19] have concluded that IRI was the detriment of renal function after PN surgery in the early postoperative period. At the same time, Bagheri et al[20] used the estimated glomerular filtration rate (eGFR) for the 1-year follow-up, and found that postoperative renal function was independent of IRI. In contrast, renal function was associated with renal volume rather than the effects of IRI at the late time point.[19] Precise segmental clamping of the renal artery can reduce damage induced by IRI after PN.[7,17,21] Many scholars have cited various criticisms, providing various trains of thought for designing a series of studies about the impact of WIT in PN. However, they were not able to arrive at a unified conclusion.

Renal function and renal volume have a strong relationship in normal humans without any disease with regard to the kidneys.[22–24] According to a study for normal volunteers, the glomerular filtration rate (GFR) is the most direct and accurate replacement indictor of renal function.[23,25] Nevertheless, the relationship between renal function and renal volume after the treatment of PN has rarely been reported.

The conclusions of previous studies on the influence of IRI have been contradicting. Hence, results on the impact of IRI after PN surgery remain inconsistent. At the same time, most of these studies used eGFR or serum creatinine to analyze factors that influence the affected renal function after PN. However, the follow-up time was too short or <5 years. During the follow-up period, aGFRpost decreased, compared with aGFRpre. We designed a 5-year retrospective cohort study and explored the cause of the decline in aGFRpost with the loss of inherent nephrons or the impact on IRI.

Back to Top | Article Outline

2 Methods

2.1 Data acquisition

Thirty-nine patients with localized renal tumors were treated by SPRN between June 2009 and April 2012 in the Affiliated Hospital of Guizhou Medical University and the Third Central Hospital of Tianjin. The present study was approved by the Ethics Committee of the Affiliated Hospital of Guizhou Medical University and the Third Central Hospital of Tianjin, and all included patients provided a signed informed consent. The inclusion criteria of the present study were as follows:

  1. patients who had an indication of PN, accepted SRPN, and was not converted to open surgery;
  2. patients with localized renal tumors, and the diameter of the tumor was not more than 4 cm;
  3. the distance between the edge of the tumor and renal pedicle should be ≥3 cm;
  4. patients with renal tumors confirmed by imaging examinations, and the stage of the tumor should not be higher than pT1a, according to the 2010 American Joint Committee on Cancer renal tumor staging criteria;
  5. preoperative renal computed tomography angiography revealed tumor blood supplied from the kidney's secondary or tertiary vessels;
  6. the GFR determined by 99mTc-DTPA technology (diethylenetriaminepentaacetic acid) and renal functions were normal.

The exclusion criteria of the study were as follows:

  1. patients with solitary kidneys;
  2. patients with a pathological diagnosis of urothelial carcinoma;
  3. patients with a preoperative history of at least 1 side kidney with a history of injury or other diseases;
  4. patients with special comorbidities effect on renal function, such as hypertention and diabetes mellitus.

Since these procedures were performed at different time periods, only patients who met the inclusion criteria and were treated by the same surgeon that could perform all the procedures skillfully were included in the study.

The data of the preoperative cases were obtained from the inpatient cases, which included gender, age, operation time, time of renal artery blocking, site and size of the tumor, pathological diagnosis, volume of the affected kidney, and GFR of the affected kidney. Patients were followed up through correspondence and visits in the Outpatient Department at the 3rd, 6th, 12th, 24th, and 60th month after the operation. The 320-row volume computed tomography (320CT) and renogram were obligatory examinations to understand the renal function, tumor recurrence, and metastasis.

The preoperative affected GFR (aGFRpre), postoperative affected GFR (aGFRpost), preoperative affected renal volume (aVolpre), and postoperative affected renal residual volume (aVolpost) were collected at during the follow-up period. The correlation between aGFRpost/aGFRpre and aVolpost/aVolpre were compared.

A series of studies for neonates concluded that the number of nephrons determines renal function,[26] the number of nephrons was fixed after 36 weeks of the fetal period,[26–28] and there was no difference between adults and children.[26,28] Furthermore, the feasibility and reliability of using the ellipsoid method to measure the volume of the kidney in CT was studied.[29] That is, renal length, lateral diameter, and anterior–posterior diameter were measured by abdominal CT using the formula: kidney volume (cm3) = length diameter (cm) × lateral diameter (cm) × anterior–posterior diameter (cm) × π/6. The preoperative and postoperative renal volumes were measured using this method (Fig. 1).

Figure 1

Figure 1

Back to Top | Article Outline

2.2 Statistical analysis

All statistical analyses were performed using SPSS software package, version 22.0. Quantitative data were presented as mean ± standard deviation, and compared using the paired-sample T test. The effects of the body mass index (BMI), operation time, WIT and distance from tumor to renal hilum on renal function were analyzed by multivariate linear regression analysis. The correlation between renal function and renal volume was compared using the Pearson product-moment correlation. Overall survival (OS) was defined as the percentage of surviving patients, and disease-free survival (DFS) was defined as the percentage of healthy patients after the 5-year follow-up. OS and DFS were evaluated by Kaplan–Meier survival analysis. P < .05 was considered statistically significant.

Back to Top | Article Outline

3 Results

After applying a series of criteria, a total of 39 SRPNs were selected for the cohort. The tumor distance from the renal hilum was 3.7 ± 0.4 cm, and the WIT of the selective segmental renal artery was 23.3 ± 3.0 min. The mean tumor size was 3.3 ± 0.5 cm. Furthermore, 17 (51.5%) patients were diagnosed with renal clear cell carcinoma, 5 (15.2%) patients were diagnosed with renal papillary carcinoma, 3 (9.1%) patients were diagnosed with chromophobe renal carcinoma, and 8 (24.2%) patients were diagnosed with angiomyolipoma, according to pathology. Moreover, aVolpre was 141.2 ± 28.8 cm3, and aGFRpre was 45.0 ± 4.9 ml/min. The patient characteristics and surgical outcomes of SRPNs for the total cohort are presented in Table 1.

Table 1

Table 1

During the follow-up period, 3 patients refused to continue the reviews in the 12th, 22nd, and 24th month after surgery (3 cases were diagnosed as angiomyolipoma, papillary carcinoma, and angiomyolipoma, respectively), a car accident occurred in 1 patient with renal contusion on the 30th month after surgery (diagnosed as chromophobe renal carcinoma), 1 patient relapsed after the 38th month (diagnosed as papillary carcinoma), and 1 patient was detected to have ureteral calculi in the 51st month after surgery (diagnosed as renal clear cell carcinoma). Furthermore, 33 patients were successfully followed up, with an 84.6% follow-up rate. OS was 100% and DFS was 91.7% (95% CI: 57.1–61.3%; Fig. 2).

Figure 2

Figure 2

At 3, 6, 12, 24, and 60 months, aVolpost was 101.1 ± 20.2, 101.7 ± 19.6, 102.2 ± 20.1, 102.5 ± 20.1, and 102.9 ± 20.6 cm3, respectively, aVolpost/aVolpre was 72.0 ± 6.6%, 72.4 ± 6.5%, 72.8 ± 6.6%, 73.0 ± 6.6%, and 73.2 ± 6.6%, respectively, aGFRpost was 34.6 ± 4.6, 34.7 ± 4.8, 34.9 ± 4.4, 35.1 ± 4.4, and 35.2 ± 4.2 ml/min, respectively (Fig. 3), and the absolute reduction of aGFR was 10.4 ± 2.3, 10.4 ± 2.6, 10.1 ± 2.4, 9.9 ± 2.4, and 9.8 ± 2.5 ml/min, respectively. Furthermore, aGFRpost decreased, compared to that in the preoperative period to a different extent, and the difference was statistically significant (P < .05, Table 2). Multivariate linear regression analysis revealed that BMI, operation time, WIT and tumor distance from the kidney had no effect on aGFRpost (Table 3, P > .05). The correlation coefficients between aGFRpost/aGFRpre and aVolpost/aVolpre were 0.659, 0.667, 0.663, 0.629, and 0.604, respectively (Table 4), and the difference was statistically significant (Table 3). Moreover, aGFRpost/aGFRpre and aVolpost/aVolpre had a strong correlation in this cohort, according to the experimental data.

Figure 3

Figure 3

Table 2

Table 2

Table 3

Table 3

Table 4

Table 4

Back to Top | Article Outline

4 Discussion

Controlling WIT for less than 40 min is suitable by traditional view.[30,31] Simmons et al considered that the critical value of WIT was 40 min, and going beyond this time wound cause irreversible damage to the kidney.[32,33] However, Gill et al[34] and Shao et al[5] held the opinion that every minute of IRI would damage renal function. The concept of “zero ischemia” was first proposed by Gill et al,[34] in which the segmental renal artery supplying the tumor was only clamped or dissected. Subsequently, Shao et al[5] applied a new surgical method of SRPN, which was recommended in clinic for the treatment to localized renal tumors. Although clamping the blood supply artery of the tumor to ensure the supply for the rest of normal nephrons was an ideal design, this approach remains controversial, because part of the nephron may be clamped, affecting postoperative renal function. With the development of endoscopic and minimally invasive techniques, as well as further in-depth renal vascular anatomy, SRPN have become a traditional surgical approach for treating localized renal tumors in our team. We strive to dissect the branch arteries of the tumor, at least dissecting to the “secondary” arteries. However, not every patient could be dissected of “tertiary” renal blood vessels[35]. Strictly speaking, the ideal “zero ischemia” is unrealistic, and IRI from part of normal nephrons remains inevitable. Based on the achievements in the past, the present study attempted to explore the correlation between affected renal function and affected renal residual volume, analyzing the causes of decreased renal function. Was the effect of IRI induced by intraoperative segmental renal arterial clamping, or the decreased inherent nephrons from the removal of part of these nephrons?

“Pseudocapsule enucleation” of the renal tumor has been highlighted in recent years. The main point of “pseudocapsule enucleation” was that a natural dissection plane was formed on the tumor tissue and its surrounding healthy renal parenchyma, and along this plane, a blunt dissection would complete the removal of the tumor.[36–38] This approach can reduce the positive margin and preserve more renal parenchyma.[39,40] The potential invasion to the pseudocapsule of the localized renal tumor makes this method have relative indications.[41,42] In low-grade tumors, “pseudocapsule enucleation“ oncology outcomes were equivalent to PN,[40] and it turned out that this surgical approach does not affect the positive margin rate, local recurrence, and survival.[43,44] Takagi et al[45] applied a 0.5-cm margin for less than 4 cm of the renal tumor, and confirmed that the positive margin rate had no significant difference between the “pseudocapsule enucleation” and PN. Oh et al[46] concluded that the margin is the most important factor of local recurrence, and an adequate visible margin guaranteed the complete removal of the tumor. Li et al[47] considered that a surgical margin of 0.5 cm was enough to prevent the local recurrence of the tumor. For localized renal carcinoma that underwent PN, the larger margin increased the difficulty of operation, induced the over-resection of nephrons, and increased morbidity due to complications, resulting in the decline of renal function.[44,46–48] The indications and margin of the “pseudocapsule enucleation” remains controversial. A technology was used for electrocoagulating tissues, providing a line of approximately 0.5 cm from the edge of the tumor, allowing the tumor to be removed intact. According to the pathological diagnosis, all surgical margins were negative. The 5-year OS was 100% and the 5-year DFS was 91.7% (95% CI: 57.1–61.3%). Merely 1 patient relapsed after the 38th month, in which the histopathologic diagnosis was papillary carcinoma. The early detection and treatment of localized renal tumor can improve the excellent prognosis of patients. Furthermore, the necessary postoperative follow-up can prolong the survival of patients and improve their quality of life.

Compared to preoperative effects on renal function, postoperative affected renal function decreased during the whole follow-up period (P < .05). BMI, operation time, WIT, and tumor distance from the kidney had no effect on aGFRpost (P > .05). The reason was that the tumor was part of the nephrons, and the removal of the tumor caused the lack of inherent nephrons, resulting in loss of renal function. The aGFRpost remains essentially unchanged (P > .05), indicating that the loss of inherent nephrons led to decreased renal function. However, this had no impact on IRI.

The correlation coefficients between aGFRpost/aGFRpre and aVolpost/aVolpre ranged from 0.604 to 0.667 (r > 0.5), and the statistical data were positively correlated. Furthermore, the difference was statistically significant (P < .05), and postoperative affected renal function and affected renal volume both had a good correlation. This implies that postoperative affected renal function is associated with affected renal volume after the operation. The IRI induced by intraoperative segmental renal arterial clamping less likely affected postoperative renal function.

In summary, the prognosis was excellent with prolonged survival after the 5-year follow-up period for patients who received SRPN for localized renal tumors. However, this affected renal function deterioration after the operation, because the tumor was a part of the nephrons. IRI induced by the temporary SRPN during the operation could not compromise for long-term postoperative renal function, which is mainly associated with the affected renal volume. We should shorten the margin and maintain nephrons as much as possible during the operation before completely removing the tumor, in case excessive excision of inherent nephrons occurs, preventing the unnecessary loss of renal function.

Several limitations of the study should not be ignored. We have no data on patients before suffering from the renal tumor. Furthermore, the present study had a small cohort size, and the outcomes would be more ideal if studies with a large sample size could be conducted, and further research with a long-term follow-ups could be carried out. Additionally, there was a lack of evaluation in the molecular level about detecting damaged renal function, such as Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in serum and urinary[49] in the study.

In SRPN, the resection of the tumor as a part of nephrons cause parenchymal loss, resulting in renal function deterioration, rather than the outcomes of IRI. Postoperative affected renal function should be considered with the affected renal parenchymal volume. We should do our best to maintain more nephrons before we could completely resect the tumor, in case of unnecessary loss of renal function.

Back to Top | Article Outline


We are particularly grateful to all the people who have given us help on our article.

Back to Top | Article Outline

Author contributions

Conceptualization: Fang-Min Chen, Rui-Jie Hu, Xi-Nan Jiang, Si-Wen Zhong, Shuai Tang.

Data curation: Fang-Min Chen, Rui-Jie Hu, Xi-Nan Jiang, Si-Wen Zhong, Shuai Tang.

Formal analysis: Fang-Min Chen, Rui-Jie Hu.

Funding acquisition: Fang-Min Chen.

Investigation: Fang-Min Chen, Shuai Tang.

Methodology: Fang-Min Chen, Rui-Jie Hu, Xi-Nan Jiang, Si-Wen Zhong.

Writing – original draft: Fang-Min Chen, Rui-Jie Hu, Xi-Nan Jiang.

Writing – review and editing: Fang-Min Chen, Rui-Jie Hu, Si-Wen Zhong, Shuai Tang.

Back to Top | Article Outline


[1]. Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015;67:913–24.
[2]. Kuusk T, Grivas N, de Bruijn R, et al. The current management of renal cell carcinoma. Minerva Med 2017;108:357–69.
[3]. Rizkala ER, Khalifeh A, Autorino R, et al. Zero ischemia robotic partial nephrectomy: sequential preplaced suture renorrhaphy technique. Urology 2013;82:100–4.
[4]. Ng CK, Gill IS, Patil MB, et al. Anatomic renal artery branch microdissection to facilitate zero-ischemia partial nephrectomy. Eur Urol 2012;61:67–74.
[5]. Shao P, Qin C, Yin C, et al. Laparoscopic partial nephrectomy with segmental renal artery clamping: technique and clinical outcomes. Eur Urol 2011;59:849–55.
[6]. Borofsky MS, Gill IS, Hemal AK, et al. Near-infrared fluorescence imaging to facilitate super-selective arterial clamping during zero-ischaemia robotic partial nephrectomy. BJU Int 2013;111:604–10.
[7]. Liang C, Zhu J, Miao C, et al. Protective effects of the segmental renal artery clamping technique on ischemia-reperfusion injury in db/db diabetic mice. Biomed Res Int 2017;2017:4763828.
[8]. Van Poppel H, Becker F, Cadedd JA, et al. Treatment of localised renal cell carcinoma. Eur Urol 2011;60:662–72.
[9]. Zhou XF, Ding ZS, Wang JF, et al. Laparoscopic partial nephrectomy by diode laser with highly selective clamping of segmental renal arterial. Chin Med J (Engl) 2015;128:2262–4.
[10]. Poon SA, Silberstein JL, Chen LY, et al. Trends in partial and radical nephrectomy: an analysis of case logs from certifying urologists. J Urol 2013;190:464–9.
[11]. Bier S, Todenhofer T, Aufderklamm S, et al. Laparoscopic partial nephrectomy for renal tumors. Time for a new standard? Urologe A 2015;54:826–31.
[12]. Becker F, Van Poppel H, Hakenberg OW, et al. Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol 2009;56:625–34.
[13]. Hung AJ, Cai J, Simmons MN, et al. “Trifecta” in partial nephrectomy. J Urol 2013;189:36–42.
[14]. Dagenais J, Maurice MJ, Mouracade P, et al. Excisional precision matters: understanding the influence of excisional volume loss on renal function after partial nephrectomy. Eur Urol 2017;72:168–70.
[15]. Choi JD, Park JW, Lee SY, et al. Does prolonged warm ischemia after partial nephrectomy under pneumoperitoneum cause irreversible damage to the affected kidney? J Urol 2012;187:802–6.
[16]. Porpiglia F, Fiori C, Bertolo R, et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol 2012;62:130–5.
[17]. Thompson RH, Lane BR, Lohse CM, et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology 2012;79:356–60.
[18]. Mir MC, Campbell RA, Sharma N, et al. Parenchymal volume preservation and ischemia during partial nephrectomy: functional and volumetric analysis. Urology 2013;82:263–8.
[19]. Simmons MN, Hillyer SP, Lee BH, et al. Functional recovery after partial nephrectomy: effects of volume loss and ischemic injury. J Urol 2012;187:1667–73.
[20]. Bagheri F, Pusztai C, Farkas L, et al. Impact of parenchymal loss on renal function after laparoscopic partial nephrectomy under warm ischemia. World J Urol 2016;34:1629–34.
[21]. Furukawa J, Miyake H, Hinata N, et al. Renal functional and perioperative outcomes of selective versus complete renal arterial clamping during robot-assisted partial nephrectomy. Surg Innov 2016;23:242–8.
[22]. Gong IH, Hwang J, Choi DK, et al. Relationship among total kidney volume, renal function and age. J Urol 2012;187:344–9.
[23]. Johnson S, Rishi R, Andone A, et al. Determinants and functional significance of renal parenchymal volume in adults. Clin J Am Soc Nephrol 2011;6:70–6.
[24]. Choi KH, Yoon YE, Kim KH, et al. Contralateral kidney volume change as a consequence of ipsilateral parenchymal atrophy promotes overall renal function recovery after partial nephrectomy. Int Urol Nephrol 2015;47:25–32.
[25]. Qiu X, Liu C, Ye Y, et al. The diagnostic value of serum creatinine and cystatin c in evaluating glomerular filtration rate in patients with chronic kidney disease: a systematic literature review and meta-analysis. Oncotarget 2017;8:72985–99.
[26]. Abitbol CL, DeFreitas MJ, Strauss J. Assessment of kidney function in preterm infants: lifelong implications. Pediatr Nephrol 2016;31:2213–22.
[27]. Bertram JF, Douglas-Denton RN, Diouf B, et al. Human nephron number: implications for health and disease. Pediatr Nephrol 2011;26:1529–33.
[28]. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992;232:194–201.
[29]. Breau RH, Clark E, Bruner B, et al. A simple method to estimate renal volume from computed tomography. Can Urol Assoc 2013;7:189–92.
[30]. Godoy G, Ramanathan V, Kanofsky JA, et al. Effect of warm ischemia time during laparoscopic partial nephrectomy on early postoperative glomerular filtration rate. J Urol 2009;181:2438–43. discussion 2443-2435.
[31]. Ricciardulli S, Ding Q, Zhang X, et al. Evaluation of PADUA score as predictor of Warm Ischemia Time (WIT) during Laparoscopic Partial Nephrectomy (LPN). Urologia 2016;83:194–9.
[32]. Simmons MN, Lieser GC, Fergany AF, et al. Association between warm ischemia time and renal parenchymal atrophy after partial nephrectomy. J Urol 2013;189:1638–42.
[33]. Ko KJ, Choi DK, Shin SJ, et al. Predictive factors of prolonged warm ischemic time (>/=30 minutes) during partial nephrectomy under pneumoperitoneum. Korean J Urol 2015;56:742–8.
[34]. Gill IS, Patil MB, Abreu AL, et al. Zero ischemia anatomical partial nephrectomy: a novel approach. J Urol 2012;187:807–14.
[35]. Zhu J, Jiang F, Li P, et al. Application and analysis of retroperitoneal laparoscopic partial nephrectomy with sequential segmental renal artery clamping for patients with multiple renal tumor: initial experience. BMC Urol 2017;17:82.
[36]. Guo G, Cai W, Zhang X. Improved laparoscopic nephron-sparing surgery for renal cell carcinoma based on the precise anatomy of the nephron. Oncol Lett 2016;12:3799–803.
[37]. Snarskis C, Calaway AC, Wang L, et al. Standardized reporting of microscopic renal tumor margins: introduction of the renal tumor capsule invasion scoring system. J Urol 2017;197:23–30.
[38]. Smith ZL, Malkowicz B. Tumor enucleation for renal cell carcinoma. J Kidney Cancer VHL 2015;2:64–9.
[39]. Lu Q, Ji C, Zhao X, et al. Histopathologic analysis of tumor bed and peritumoral pseudocapsule after in vitro tumor enucleation on radical nephrectomy specimen for clinical T1b renal cell carcinoma. Urol Oncol 2017;35: 603.e615-603.e620.
[40]. Calaway AC, Gondim DD, Flack CK, et al. Anatomic comparison of traditional and enucleation partial nephrectomy specimens. Urol Oncol 2017;35:221–6.
[41]. Minervini A, Rosaria Raspollini M, Tuccio A, et al. Pathological characteristics and prognostic effect of peritumoral capsule penetration in renal cell carcinoma after tumor enucleation. Urol Oncol 2014;32: 50 e15-22.
[42]. Gupta GN, Boris RS, Campbell SC, et al. Tumor enucleation for sporadic localized kidney cancer: pro and con. J Urol 2015;194:623–5.
[43]. Minervini A, Ficarra V, Rocco F, et al. Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 2011;185:1604–10.
[44]. Wang L, Hughes I, Snarskis C, et al. Tumor enucleation specimens of small renal tumors more frequently have a positive surgical margin than partial nephrectomy specimens, but this is not associated with local tumor recurrence. Virchows Arch 2017;470:55–61.
[45]. Takagi T, Kondo T, Tachibana H, et al. Comparison of surgical outcomes between resection and enucleation in robot-assisted laparoscopic partial nephrectomy for renal tumors according to the surface-intermediate-base margin score: a propensity score-matched study. J Endourol 2017.
[46]. Oh JJ, Lee JK, Kim K, et al. Comparison of the width of peritumoral surgical margin in open and robotic partial nephrectomy: a propensity score matched analysis. PloS One 2016;11:e0158027.
[47]. Li QL, Guan HW, Zhang QP, et al. Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur Urol 2003;44:448–51.
[48]. Couapel JP, Bensalah K, Bernhard JC, et al. Is there a volume-outcome relationship for partial nephrectomy? World J Urol 2014;32:1323–9.
[49]. Giuseppe Lucarelli, Vito Mancini, Vanessa Galleggiante, et al. Emerging urinary markers of renal injury in obstructive nephropathy. Biomed Res Int 2014;2014:303298.

affected renal residual volume; ischemia-reperfusion injury; laparoscope; nephron-sparing partial nephrectomy; postoperative affected renal function; renal tumor; segmental renal artery blocking

Copyright © 2019 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.